Accelerated atherosclerosis and coronary disease in SLE

Lupus

Volumn 6, Issue 7, 1997, Pages 572-577

  Farhey, Y ^a   Hess, E V ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Accelerated atherosclerosis; Coronary disease

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; CASE REPORT; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DISEASE COURSE; ETIOLOGY; FEMALE; HEART INFARCTION; HUMAN; MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030884678     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600704     Document Type: Article

References (27)

1. Ames PRJ. Medical perspective: antiphospholipid antibodies, thrombosis and atherosclerosis in SLE: a unifying 'Membrane Stress Syndrome' Hypothesis Lupus 1994; 3: 371-377.
2. Kong TQ, Kellum RE, Haserik JR. Clinical diagnosis of cardiac involvement in SLE. A correlation of clinical and autopsy findings in thirty patients Circulation 1962; 26: 7-11.
3. Meller J et al. Myocardial Infarction due to coronary atherosclerosis in three young adults with SLE Am J Cardiol 1981; 35: 309-314.
4. Bulkley BH, Roberts WC. The heart in SLE and the changes induced in it by corticosteroid therapy. Am J Med 1978; 58: 243-264.
5. Boumpas DT et al SLE: emerging concepts. Part 1 Renal, neuropsychiatric, cardiovascular, pulmonary and hematologic disease Ann Inter Med 1995; 122: 940-950.
6. Sturfeit G et al Cardiovascular disease in SLE. Medicine 1992; 71: 216-223.
7. Moroni G et al. Cardiologic abnormalities in patients with long-term lupus nephritis. Clin Nephrol 1995; 43: 20-28.
8. De Inocencio J Lowell DJ. Cardiac function in SLE. J Rheumatol 1994; 21: 2147-2156.
9. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with SLE. Am J Med 1992; 93: 513-519.
10. Petri M et al Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort Medicine 1992; 71: 291-303.
11. Hodis HN et al The lipid, lipoprotein and apolipoprotein effects of hydroxychloroquine in patients with SLE. J Rheumatol 1993; 20: 661-665.
12. Beisigel U St, Clair RW. An emerging understanding of the interactions of plasma lipoproteins with the arterial wall that leads to the development of atherosclerosis. Cutt Opin Lipid 1996; 7: 265-268.
13. Berliner JA et al. Atherosclerosis: basic mechanisms; oxidation, inflammation and genetics. Circulation 1995; 91: 2488-2496.
14. Witzum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogeneses. J Clin Invest 1991; 88: 1785-1792.
15. Witzum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
16. Drake TA et al. Minimally oxidized LDL induce tissue factor expression in cultured human endothelial cells. Am J Pathol 1991; 138: 601-607
17. Brand L et al. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent moncytes. Atheroscl Thromb 1994; 14: 790-797.
18. Lopes-Virella MF Virrella GT. Atherosclerosis and autoimmunity. Clin Immunol Immunopathol 1994; 73: 155-167.
19. Wick G et al. Is atherosclerosis an immunologically mediated disease? Immol Today 1995; 16: 27-33.
20. Kabakov AE et al. The atherogenic effect of lupus sera: SLE-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin Immunol Immunopathol 1992; 63: 214-220.
21. De Caterina R, D'Ascanio A, Mazzone A. Prevalence of anticardiolipin antibodies in coronary artery disease. Am J Cardiol 1990; 65: 922-924.
22. Asherson RA et al. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med 1989; 73: 1103-1105.
23. Schwartz SM, Reidy MA, O'Brien ER. Assessment of factors important in atherosclerosis occlusion and restenosis. Thromb Hemost 1995; 74: 541-551.
24. Neumann K. et al. Lupus in the 1980s. III. Influence of clinical variables, biopsy and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 1995; 25: 44-55.
25. Maxwell SRJ, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 1994; 70: 863-870.
26. Krakoff LR. Corticosteroid excess syndromes causing hypertension. Cardiol Clin 1988; 6: 537-545.
27. Golodfine JD et al. Decreased binding of insulin to its receptors in rats with hormone-induced resistance. Biochem Biophys Res Commun 1973; 53: 852-857.